Any current/future new fundraising through debt or equity?

No explicit mention of any ongoing or planned fundraising through debt or equity in the provided transcript. The company maintains a strong balance sheet with surplus funds invested in Board-approved securities. New investments and capex, such as setting up phosphoric and sulphuric acid plants, are being funded primarily through internal accruals. The management indicates no immediate impact on margins or operations due to financial constraints. Discussions suggest investments are evaluated on IRR and payback basis, with projects funded internally rather than through external borrowing. The co

Any current/future capex/capital investment/strategic investment?

Approved plan to expand backward integration capabilities by setting up phosphoric acid and sulphuric acid plants at Kakinada Fertilizer Unit, subject to regulatory approvals (Page 6). Debottlenecking options and capacity enhancement within existing plants underway; updates expected in future calls (Page 11 and 17). Investment in new manufacturing facility for Dhaksha (drone-related business), with line moving next month to improve operations (Page 18). Focus on repurposing some assets for specialty chemicals and progress on CDMO (Contract Development and Manufacturing Organization) front,

Future growth expectations in sales/revenue/volumes?

Crop Protection segment expects growth from new products, specialty chemicals, and CDMO opportunities, with efforts on focused chemistries and improved efficiencies. Volume growth observed in last two quarters in Crop Protection despite global challenges; expected to continue improving market share through increased product quantities in both domestic and export markets. Backward integration projects (phosphoric and sulphuric acid plants) will improve cost efficiency and raw material security, supporting future growth. Retail business expanding footprint with 50 new stores planned by year-end,

Future growth expectations in earnings/operating earnings/profits/EPS?

The company anticipates volume growth particularly in Crop Protection Chemicals (CPC), supported by new products and focused district-specific plans, which should improve market share and resilience despite global headwinds. (Pages 18-19) Backward integration projects (phosphoric and sulphuric acid plants) are expected to improve raw material security, cost efficiencies, and support earnings growth, with capex around Rs. 1,000 crores underway. (Pages 6, 16-17) Margin improvement efforts include efficiency enhancements within factories and product mix optimization, aiming at gross margin expa

Coromandel International LtdQ3 FY24Fertilizers & Agrochemicals

Coromandel International Ltd Q3 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹1,764P/E: 31.0Market Cap: ₹57.9K CrSector: Fertilizers & Agrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

Yes

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 3

Crop Protection segment expects growth from new products, specialty chemicals, and CDMO opportunities, with efforts on focused chemistries and improved efficiencies.
Volume growth observed in last two quarters in Crop Protection despite global challenges; expected to continue improving market share through increased product quantities in both domestic and export markets.
Backward integration projects (phosphoric and sulphuric acid plants) will improve cost efficiency and raw material security, supporting future growth.
Retail business expanding footprint with 50 new stores planned by year-end, focusing on crop-specific products and data-driven customer targeting to drive sales.
Dhaksha drone business showing strong order book (~Rs. 300 crores) with growth potential across agriculture, defense, and enterprise sectors, backed by new manufacturing capacity.
Representations underway to government for subsidy revisions to support better margins and volume growth.
Overall, pipeline for new product launches and diversified business segments signify robust medium-term growth prospects.

Margin guidance

Category 3

The company anticipates volume growth particularly in Crop Protection Chemicals (CPC), supported by new products and focused district-specific plans, which should improve market share and resilience despite global headwinds. (Pages 18-19)
Backward integration projects (phosphoric and sulphuric acid plants) are expected to improve raw material security, cost efficiencies, and support earnings growth, with capex around Rs. 1,000 crores underway. (Pages 6, 16-17)
Margin improvement efforts include efficiency enhancements within factories and product mix optimization, aiming at gross margin expansion despite price erosions. (Pages 18, 11-12)
Current margins are below normalized guidance due to subsidy and pricing pressures, but full-year basis and potential subsidy revisions could support margin normalization. (Pages 14-15)
The company remains cautious on near-term price hikes due to market conditions but is optimistic on subsidy revisions and policy clarity to support earnings. (Pages 14-15)
New business lines like Dhaksha (drones) offer growth potential with an order book of Rs. 300 crores, diversifying earnings. (Page 18)
Overall, growth hinges on market environment, policy clarity, and successful capacity expansions, with management aiming for stable or improved margins in coming periods.

See what Coromandel International Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

No explicit mention of any ongoing or planned fundraising through debt or equity in the provided transcript.
The company maintains a strong balance sheet with surplus funds invested in Board-approved securities.
New investments and capex, such as setting up phosphoric and sulphuric acid plants, are being funded primarily through internal accruals.
The management indicates no immediate impact on margins or operations due to financial constraints.
Discussions suggest investments are evaluated on IRR and payback basis, with projects funded internally rather than through external borrowing.
The company is focusing on tightly managing working capital rather than raising new debt or equity at present.

Order book

Yes

- Dhaksha, a subsidiary/division of Coromandel, currently has an order book of close to Rs. 300 crores. - The order book spans multiple segments including agriculture, defense, and enterprise. - There is significant government emphasis on promoting drones for agriculture, especially through women self-help groups, targeting close to 15,000 drones over the next couple of years. - Dhaksha is supplying drones to IFFCO and Coromandel for agricultural use. - Additional orders come from logistics and defense sectors, which form a large portion of the current order book. - Enterprise solutions have also received a couple of orders. - Ongoing R&D and a new manufacturing facility setup are supporting order fulfillment and future growth. (Information source: Q&A discussion on pages 18-19)

See what Coromandel International Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes

Approved plan to expand backward integration capabilities by setting up phosphoric acid and sulphuric acid plants at Kakinada Fertilizer Unit, subject to regulatory approvals (Page 6).
Debottlenecking options and capacity enhancement within existing plants underway; updates expected in future calls (Page 11 and 17).
Investment in new manufacturing facility for Dhaksha (drone-related business), with line moving next month to improve operations (Page 18).
Focus on repurposing some assets for specialty chemicals and progress on CDMO (Contract Development and Manufacturing Organization) front, including herbicide plant infrastructure at Dahej facility (Page 20).
Continued internal investments from surplus funds approved by the Board, earmarked for growth-related projects (Page 6).

Track Coromandel International Ltd — get its next earnings analysis in your feed

How does Coromandel International Ltd rank vs peers in Fertilizers & Agrochemicals?

Pro feature

ThisCoromandel International Ltd

Rev 3Mar 3

See where Coromandel International Ltd sits in Fertilizers & AgrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does Coromandel International Ltd rank in Fertilizers & Agrochemicals?

Compare Coromandel International Ltd against every Fertilizers & Agrochemicals company (Q3 FY24) on revenue, margins and earnings-call signals.

View Fertilizers & Agrochemicals leaderboard →

What Coromandel International Ltd's management said in earlier quarters

Others in Fertilizers & Agrochemicals this season

Advance Agrolife Ltd (Q4 FY26)
Q4 FY26 total revenue: ₹1,259.07 million, up 40% YoY (Page 24). Key concall takeaways from Advance Agrolife Ltd's Q4 FY26 earnings call — and how it ranks…
Advance Agrolife Ltd (Q1 FY27)
Q1 FY27 revenue from operations: ₹3,304 million, a 96% year-on-year (YoY) increase (Page 23, 25, 22). Key concall takeaways from Advance Agrolife Ltd's Q1 FY27…
Bhagiradha Chemicals & Industries Ltd (Q4 FY26)
158.1 crores . Key concall takeaways from Bhagiradha Chemicals & Industries Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.
Bhagiradha Chemicals & Industries Ltd (Q1 FY27)
195.0 crore . Key concall takeaways from Bhagiradha Chemicals & Industries Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.

Compare:vs Fertilizers & Chemicals Travancore Ltd vs UPL vs P I Industries

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Coromandel International Ltd Q3 FY24 Earnings Call Analysis

Revenue guidance

Fundraise plans

Capex plans

How does Coromandel International Ltd rank in Fertilizers & Agrochemicals?

Continue your research

What Coromandel International Ltd's management said in earlier quarters

Others in Fertilizers & Agrochemicals this season